(S (NP (NP (JJ Quantitative) (NN susceptibility) (NN mapping)) (PRN (-LRB- -LRB-) (NP (NNP QSM)) (-RRB- -RRB-))) (VP (VBZ utilizes) (NP (NNP MRI) (JJ signal) (NN phase)) (S (VP (TO to) (VP (VB infer) (NP (NP (NNS estimates)) (PP (IN of) (NP (NP (JJ local) (NN tissue) (NN magnetism)) (PRN (-LRB- -LRB-) (NP (JJ magnetic) (NN susceptibility)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (ADJP (JJ useful) (S (VP (S (VP (TO to) (VP (VB provide) (NP (JJ novel) (NN image) (NN contrast))))) (CC and) (PP (IN as) (NP (NP (NNS biomarkers)) (PP (IN of) (NP (JJ abnormal) (NN tissue))))))))))))))))))))) (. .))
(S (NP (NNP QSM)) (VP (VBZ requires) (S (VP (VBG addressing) (NP (NP (DT a) (JJ challenging) (NN post-processing) (NN problem)) (: :) (NP (NP (NP (NN filtering)) (PP (IN of) (NP (NN image) (NN phase) (NNS estimates)))) (CC and) (NP (NP (NN inversion)) (PP (IN of) (NP (DT the) (NAC (NN phase) (PP (TO to) (NP (NN susceptibility)))) (NN relationship))))))))) (. .))
(S (NP (NP (DT A) (JJ wide) (NN variety)) (PP (IN of) (NP (NP (NN quantification) (NNS errors)) (, ,) (NP (NN robustness) (NNS limitations)) (, ,) (CC and) (NP (VBZ artifacts))))) (VP (JJ plague) (NP (NNP QSM) (NN algorithms))) (. .))
(S (S (VP (TO To) (VP (VB overcome) (NP (DT these) (NNS limitations))))) (, ,) (NP (DT a) (JJ robust) (JJ deep-learning-based) (NN single-step) (NNP QSM) (NN reconstruction) (NN approach)) (VP (VBZ is) (VP (VBN proposed) (CC and) (VBN demonstrated))) (. .))
(S (NP (DT This) (JJ neural) (NN network)) (VP (VBD was) (VP (VBN trained) (S (VP (VBG using) (NP (NP (JJ magnetostatic) (NNS physics) (NNS simulations)) (VP (VBN based) (PP (IN on) (NP (JJ in-vivo) (NNS data) (NNS sources))))))))) (. .))
(S (NP (JJ Random) (NNS perturbations)) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (DT the) (NNS physics) (NNS simulations))) (S (VP (TO to) (VP (VB provide) (NP (JJ sufficient) (JJ input-label) (NNS pairs)) (PP (IN for) (NP (DT the) (NN training) (NNS purposes)))))))) (. .))
(S (NP (DT The) (NN network)) (VP (VBD was) (VP (ADVP (RB quantitatively)) (VBN tested) (S (VP (VBG using) (NP (JJ gold-standard) (ADJP (NN in-silico) (VBD labeled)) (NNS datasets)) (PP (IN against) (NP (VBN established) (NNP QSM) (JJ total) (NN field) (NN inversion) (NNS approaches))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN algorithm)) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NP (JJ susceptibility-weighted) (NN imaging) (PRN (-LRB- -LRB-) (NNP SWI) (-RRB- -RRB-)) (NNS data)) (VP (VBN collected) (PP (IN on) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (NP (JJ clinical) (NNS subjects)) (PP (IN with) (NP (NN brain) (NN hemmhorage)))))))))))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (VP (ADVP (RB quantitatively)) (VBN compared) (PP (IN against) (NP (JJ gold-standard) (JJ in-silico) (NNS labels)))))) (, ,) (NP (DT the) (VBN proposed) (NN algorithm)) (VP (VBD outperformed) (NP (DT the) (VBG existing) (JJ comparable) (NNS approaches))) (. .))
(S (NP (JJ High) (NN quality) (NNP QSM)) (VP (VBD were) (VP (ADVP (RB consistently)) (VBN estimated) (PP (IN from) (NP (NP (JJ clinical) (JJ susceptibility-weighted) (NNS data)) (PP (IN on) (NP (CD 100) (NNS subjects))))) (PP (IN without) (NP (DT any) (JJ noticeable) (NN inversion) (NNS failures))))) (. .))
(S (NP (DT The) (VBN proposed) (NN approach)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (ADVP (VB robustly)) (JJ generate) (NP (ADJP (JJ high) (NN quality)) (NNP QSM)) (PP (IN with) (NP (JJ improved) (NN accuracy))) (PP (IN in) (NP (JJ in-silico) (JJ gold-standard) (NNS experiments)))))))) (. .))
(S (NP (NP (NNP QSM)) (VP (VBN produced) (PP (IN by) (NP (DT the) (VBN proposed) (NN method))))) (VP (MD can) (VP (VP (VB be) (VP (VBN generated) (PP (IN in) (NP (NN real-time))) (PP (IN on) (NP (VBG existing) (NNP MRI) (NN scanner) (NNS platforms))))) (CC and) (VP (VB provide) (NP (NP (VBN enhanced) (NN visualization) (CC and) (NN quantification)) (PP (IN of) (NP (JJ magnetism-based) (NN tissue) (NNS contrasts))))))) (. .))
